Paul Stockhammer
Paul Stockhammer publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Pleural and Pulmonary Diseases, Occupational and environmental lung diseases and Lung Cancer Treatments and Mutations.
- World rank
- #2,581,359 of 7,710,434 ranked researchers
- Rank in Germany
- #127,893 of 364,343
- Works
- 106
- Citations
- 471
- Citations per work
- 4.4
What does Paul Stockhammer research?
Paul Stockhammer's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (16%), Chemistry (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6561.7%
- Medicine6561.7%
- Life Sciences1715.8%
- Everything else1615.0%
- Physical Sciences87.5%
- Chemistry87.5%
- 1Pulmonary and Respiratory Medicine45% of their works
- 2Oncology12% of their works
- 3Molecular Biology12% of their works
- 4Organic Chemistry8% of their works
- 5Surgery4% of their works
- 6Cell Biology3% of their works
Research topics
Which keywords describe Paul Stockhammer's research?
The keywords of their largest research topics: Immunotherapy, Clinical Trials, Targeted Therapy, BAP1 mutations, Empyema, Malignant Pleural Mesothelioma, Pleural Effusion and ALK Inhibitors.
- Histone Deacetylases
- BRAF gene
- CT Screening
- Genomic Profiles
- Pulmonary Alveolar Microlithiasis
- Chemotherapy
- ALK Inhibitors
- Malignant Pleural Mesothelioma
- BAP1 mutations
- Clinical Trials
- Immunotherapy
- Targeted Therapy
- Empyema
- Pleural Effusion
- EGFR Mutations
- Cancer Therapy
- Pulmonary Sclerosing Hemangioma
- Small-Cell Lung Cancer
- Lung Cancer
- HDAC Inhibitors
- MAP Kinase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Immunotherapy182 topics
- Clinical Trials172 topics
- Targeted Therapy172 topics
- BAP1 mutations131 topic
- Empyema131 topic
- Malignant Pleural Mesothelioma131 topic
- Pleural Effusion131 topic
- ALK Inhibitors121 topic
- EGFR Mutations121 topic
- Chemotherapy92 topics
- Cancer Therapy62 topics
- Pulmonary Alveolar Microlithiasis61 topic
- Pulmonary Sclerosing Hemangioma61 topic
- Genomic Profiles51 topic
- Small-Cell Lung Cancer51 topic
- CT Screening41 topic
- Lung Cancer41 topic
- BRAF gene31 topic
- HDAC Inhibitors31 topic
- Histone Deacetylases31 topic
- MAP Kinase31 topic
Where does Paul Stockhammer work?
Paul Stockhammer's main affiliation in the publication record is Ruhrlandklinik, Germany.
How many publications and citations does Paul Stockhammer have?
OpenAlex counts 106 works and 471 citations for Paul Stockhammer, an h-index of 12, ranking #2,581,359 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paul Stockhammer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.